Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Exp Med ; 187(4): 571-8, 1998 Feb 16.
Artículo en Inglés | MEDLINE | ID: mdl-9463407

RESUMEN

The orphan receptor CRF2-4 is a member of the class II cytokine receptor family (CRF2), which includes the interferon receptors, the interleukin (IL) 10 receptor, and tissue factor. CRFB4, the gene encoding CRF2-4, is located within a gene cluster on human chromosome 21 that comprises three interferon receptor subunits. To elucidate the role of CRF2-4, we disrupted the CRFB4 gene in mice by means of homologous recombination. Mice lacking CRF2-4 show no overt abnormalities, grow normally, and are fertile. CRF2-4 deficient cells are normally responsive to type I and type II interferons, but lack responsiveness to IL-10. By approximately 12 wk of age, the majority of mutant mice raised in a conventional facility developed a chronic colitis and splenomegaly. Thus, CRFB4 mutant mice recapitulate the phenotype of IL-10-deficient mice. These findings suggest that CRF2-4 is essential for IL-10-mediated effects and is a subunit of the IL-10 receptor.


Asunto(s)
Glicoproteínas de Membrana , Receptores de Citocinas/fisiología , Receptores de Interleucina/fisiología , Animales , Separación Celular , Células Cultivadas , Colitis/inmunología , Citometría de Flujo , Interferón-alfa/farmacología , Interferón gamma/farmacología , Subunidad beta del Receptor de Interleucina-10 , Linfocitos/efectos de los fármacos , Linfocitos/inmunología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Ratones , Ratones Endogámicos C57BL , Conformación Proteica , Receptores de Citocinas/genética , Receptores de Citocinas/inmunología , Receptores de Interleucina/genética , Receptores de Interleucina/inmunología , Receptores de Interleucina-10 , Esplenomegalia/inmunología , Células Madre/efectos de los fármacos , Células Madre/inmunología , Transfección
2.
Neuron ; 19(1): 15-26, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9247260

RESUMEN

Sonic hedgehog (Shh) is a putative morphogen secreted by the floor plate and notochord, which specifies the fate of multiple cell types in the ventral aspect of the vertebrate nervous system. Since in Drosophila the actions of Hh have been shown to be transduced by Cubitus interruptus (Ci), a zinc finger transcription factor, we examined whether a vertebrate homolog of this protein can mediate the functions of Shh in the vertebrate nervous system. Here, we demonstrate that expression of Gli-1, one of three vertebrate homologs of Ci, can be induced by Shh in the neural tube. Further, ectopic expression of Gli-1 in the dorsal midbrain and hindbrain of transgenic mice mimics the effects of ectopically expressed Shh-N, leading to the activation of ventral neural tube markers such as Ptc, HNF-3beta, and Shh; to the suppression of dorsal markers such as Pax-3 and AL-1; and to the formation of ectopic dorsal clusters of dopaminergic and serotonergic neurons. These findings demonstrate that GLI-1 can reproduce the cell patterning actions of Shh in the developing nervous system and provide support for the hypothesis that it is a mediator of the Shh signal in vertebrates.


Asunto(s)
Encéfalo/crecimiento & desarrollo , Diferenciación Celular/genética , Neuronas/fisiología , Proteínas Oncogénicas/fisiología , Factores de Transcripción/fisiología , Dedos de Zinc , Animales , Encéfalo/metabolismo , Ratones , Ratones Transgénicos , Ratas
3.
Nature ; 372(6506): 560-3, 1994 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-7990930

RESUMEN

Tumour necrosis factor (TNF) elicits multiple biological effects through two distinct cell surface receptors, TNF-R1 (p55) and TNF-R2 (p75). Most TNF-mediated biological responses, such as cell death, gene induction, antiviral activity and cytokine production, have been attributed to TNF-R1 (refs 1-5). Gene targeting of this receptor confirms its role in the lethality attributable to low doses of lipopolysaccharide after sensitization with D-galactosamine; surprisingly, the toxicity of high doses of lipopolysaccharide was unaffected. The function of TNF-R2 is less well understood, although there are data supporting a role in T-cell development and the proliferation of cytotoxic T lymphocytes. To clarify the physiological role of TNF-R2, we have generated mice deficient in this receptor by gene targeting. The TNF-R2-/- mice show normal T-cell development and activity, but we find that they have increased resistance to TNF-induced death. Additionally, such mice injected subcutaneously with TNF show a dramatic decrease in tissue necrosis, indicating that this receptor plays a role in the necrotic effects of TNF.


Asunto(s)
Antígenos CD , Receptores del Factor de Necrosis Tumoral/metabolismo , Linfocitos T/citología , Factor de Necrosis Tumoral alfa/fisiología , Animales , Antígenos de Diferenciación/metabolismo , Linfocitos B/citología , Diferenciación Celular/fisiología , Marcación de Gen , Humanos , Listeriosis/inmunología , Ratones , Necrosis/inmunología , Receptores del Factor de Necrosis Tumoral/genética , Receptores Tipo II del Factor de Necrosis Tumoral , Piel/inmunología , Piel/patología , Linfocitos T/metabolismo , Timo/citología
4.
Science ; 265(5172): 682-4, 1994 Jul 29.
Artículo en Inglés | MEDLINE | ID: mdl-8036519

RESUMEN

Interleukin-8 (IL-8) is a proinflammatory cytokine that specifically attracts and activates human neutrophils. A murine gene with a high degree of homology to the two known human IL-8 receptors was cloned and then deleted from the mouse genome by homologous recombination in embryonic stem (ES) cells. These mice, although outwardly healthy, had lymphadenopathy, resulting from an increase in B cells, and splenomegaly, resulting from an increase in metamyelocytes, band, and mature neutrophils. Thus, this receptor may participate in the expansion and development of neutrophils and B cells. This receptor was the major mediator of neutrophil migration to sites of inflammation and may provide a potential therapeutic target in inflammatory disease.


Asunto(s)
Linfocitos B/patología , Inflamación/inmunología , Neutrófilos/patología , Receptores de Interleucina/fisiología , Animales , Médula Ósea/patología , Movimiento Celular/fisiología , Quimera , Hematopoyesis Extramedular/fisiología , Recuento de Leucocitos , Ganglios Linfáticos/patología , Ratones , Ratones Endogámicos C57BL , Receptores de Interleucina/deficiencia , Receptores de Interleucina/genética , Receptores de Interleucina-8B , Recombinación Genética , Bazo/patología , Células Madre
5.
Cell ; 76(6): 1001-11, 1994 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-8137419

RESUMEN

Homologous recombination was utilized to generate mice with a deletion in the coding sequence of the nerve growth factor (NGF) gene. Animals homozygous for NGF disruption failed to respond to noxious mechanical stimuli, and histological analysis revealed profound cell loss in both sensory and sympathetic ganglia. Within dorsal root ganglia, effects of the mutation appeared to be restricted to small and medium peptidergic neurons. These observations confirm the critical dependence of sensory and sympathetic neurons on NGF and demonstrate that other neurotrophins are not able to compensate for the loss of NGF action on these cells. Examination of the central nervous system revealed that, in marked contrast with neurons of sensory and sympathetic ganglia, basal forebrain cholinergic neurons differentiate and continue to express phenotypic markers for the life span of the null mutant mice. Thus, differentiation and initial survival of central NGF-responsive neurons can occur in the absence of NGF.


Asunto(s)
Fibras Colinérgicas/fisiología , Ganglios Simpáticos/citología , Factores de Crecimiento Nervioso/fisiología , Neuronas Aferentes/fisiología , Prosencéfalo/citología , Animales , Femenino , Ganglios Espinales/citología , Ganglios Simpáticos/embriología , Eliminación de Gen , Homocigoto , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes , Mosaicismo , Factores de Crecimiento Nervioso/genética , Umbral del Dolor/fisiología , Prosencéfalo/embriología
6.
Genes Dev ; 7(12B): 2609-17, 1993 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8276243

RESUMEN

IGF-I is a pleiotropic hormone reported to affect linear growth, glucose metabolism, organ homeostasis, and the immune and neurologic systems. In contrast to IGF-II, IGF-I is expressed at low levels embryonically and has been thought to be more important for postnatal growth and development. To investigate the role of IGF-I in normal development we generated mice with an inactive IGF-I gene by homologous recombination in ES cells. Heterozygous mice are healthy and fertile, but they are 10-20% smaller than wild-type littermates and have lower than normal levels of IGF-I. The size reduction is attributable to a decrease in organs and muscle and bone mass. However, all tissues appear histologically normal. At birth homozygous mutant mice (IGF-I-/-) are < 60% body weight of wild type. Greater than 95% of IGF-I-/- pups die perinatally. Histopathology is characterized by underdevelopment of muscle tissue. Lungs of late embryonic and neonates also appeared less organized with ill-defined alveolae. IGF-I appears to be essential for correct embryonic development in mice.


Asunto(s)
Desarrollo Embrionario y Fetal/fisiología , Factor I del Crecimiento Similar a la Insulina/fisiología , Ratones/embriología , Animales , Secuencia de Bases , Línea Celular , Femenino , Factor I del Crecimiento Similar a la Insulina/deficiencia , Factor I del Crecimiento Similar a la Insulina/genética , Masculino , Ratones/anomalías , Ratones/genética , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Fenotipo , Embarazo
8.
Science ; 260(5116): 1942-6, 1993 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-8100367

RESUMEN

Type I diabetes is an autoimmune disease involving an interaction between an epigenetic event (possibly a viral infection), the pancreatic beta cells, and the immune system in a genetically susceptible host. The possibility that the type I interferons could mediate this interaction was tested with transgenic mice in which the insulin-producing beta cells expressed an interferon-alpha. These mice developed a hypoinsulinemic diabetes associated with a mixed inflammation centered on the islets. The inflammation and the diabetes were prevented with a neutralizing antibody to the interferon-alpha. Thus, the expression of interferon-alpha by the beta cells could be causal in the development of type I diabetes, which suggests a therapeutic approach to this disease.


Asunto(s)
Diabetes Mellitus Tipo 1/etiología , Interferón-alfa/biosíntesis , Islotes Pancreáticos/metabolismo , Animales , Anticuerpos Monoclonales/uso terapéutico , Relación CD4-CD8 , Linfocitos T CD4-Positivos , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/patología , Femenino , Glucagón/análisis , Insulina/análisis , Insulina/sangre , Interferón-alfa/inmunología , Islotes Pancreáticos/inmunología , Islotes Pancreáticos/patología , Leucocitos Mononucleares , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Pruebas de Neutralización , Somatostatina/análisis
9.
Science ; 259(5102): 1739-42, 1993 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-8456300

RESUMEN

Interferon-gamma (IFN-gamma) is a pleiotrophic cytokine with immunomodulatory effects on a variety of immune cells. Mice with a targeted disruption of the IFN-gamma gene were generated. These mice developed normally and were healthy in the absence of pathogens. However, mice deficient in IFN-gamma had impaired production of macrophage antimicrobial products and reduced expression of macrophage major histocompatibility complex class II antigens. IFN-gamma-deficient mice were killed by a sublethal dose of the intracellular pathogen Mycobacterium bovis. Splenocytes exhibited uncontrolled proliferation in response to mitogen and alloantigen. After a mixed lymphocyte reaction, T cell cytolytic activity was enhanced against allogeneic target cells. Resting splenic natural killer cell activity was reduced in IFN-gamma-deficient mice. Thus, IFN-gamma is essential for the function of several cell types of the murine immune system.


Asunto(s)
Inmunidad , Interferón gamma/genética , Animales , División Celular , Citotoxicidad Inmunológica , Antígenos de Histocompatibilidad Clase II/inmunología , Interferón gamma/fisiología , Isoantígenos/inmunología , Células Asesinas Naturales/inmunología , Prueba de Cultivo Mixto de Linfocitos , Macrófagos/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Mutación , Mycobacterium bovis , Óxido Nítrico/metabolismo , Bazo/citología , Bazo/inmunología , Linfocitos T/inmunología , Transfección , Tuberculosis/inmunología
10.
Mol Cell Biol ; 12(12): 5541-7, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1448085

RESUMEN

Growth hormone (GH) is an important regulator of postnatal growth, acting on a wide variety of target tissues. Here, we show that local production of GH in osteoblasts is able to stimulate bone growth directly without significant systemic effects. Mice were made transgenic by microinjection of an osteocalcin-human GH (osteocalcin-hGH) gene construct in which approximately 1,800 bp of the rat osteocalcin promoter was fused to the hGH gene. Five lines of transgenic mice, each with measurable amounts of serum hGH (ranging from 1 to 1,000 ng/ml), were analyzed. Northern (RNA) blot hybridization showed that the hGH transcript was detectable only in the bone. Further characterization of hGH mRNA distribution by in situ hybridization revealed that in neonates the most intense signal was found in periosteal osteoblasts, while in adults, trabecular and endosteal osteoblasts were favored. In one transgenic line (992-1), hGH was expressed at a much lower level and had minimal systemic effects; however, the local concentrations of hGH in bone were sufficient to stimulate bone growth in these animals.


Asunto(s)
Desarrollo Óseo , Hormona del Crecimiento/genética , Osteoblastos/metabolismo , Osteocalcina/metabolismo , Animales , Northern Blotting , Clonación Molecular , Hormona del Crecimiento/metabolismo , Hibridación in Situ , Ratones , Ratones Transgénicos , Especificidad de Órganos/genética , Ratas
11.
Endocrinology ; 130(1): 405-14, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1727714

RESUMEN

Multiple peptide hormones can be derived from the single human GH gene. In addition to the full-length 191-amino acid 22-kilodalton (kDa) form, a 20-kDa variant can be produced by alternative splicing, and a 5-kDa variant can be produced by posttranslational cleavage. To more fully appreciate the physiological roles of these proteins, we have made a comparison of transgenic mice that constitutively overexpress one or another of these variants. We have found that both the 22-kDa and the 20-kDa forms of human GH stimulate linear growth and liver hypertrophy. The increase in linear growth in 22-kDa transgenic mice does not, however, correlate with an increase in circulating IGF-I; rather, the increase in IGF-I that does finally occur correlates with marked liver pathology. Both groups of mice also develop glomerulosclerosis and suffer from hyperinsulinemia. Although there are histologically obvious lesions in the livers of both the 22-kDa and the 20-kDa transgenic mice, only the former exhibit hyperalbuminemia and hypercholesterolemia. Both forms of GH lead to anemia, which is normocytic in the 20-kDa transgenic mice and macrocytic in the 22-kDa transgenic mice. Despite the presence of high levels of the 5-kDa N-terminal form of human GH, the transgenic mice that express this protein are indistinguishable from their nontransgenic littermates.


Asunto(s)
Hormona del Crecimiento/fisiología , Fragmentos de Péptidos/fisiología , Animales , Femenino , Glucosa/metabolismo , Crecimiento , Hormona del Crecimiento/análisis , Hormona del Crecimiento/genética , Hematopoyesis , Factor I del Crecimiento Similar a la Insulina/análisis , Riñón/patología , Hígado/metabolismo , Hígado/patología , Ratones , Ratones Transgénicos , Tamaño de los Órganos
12.
New Biol ; 2(12): 1101-10, 1990 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1965148

RESUMEN

It is well established that insulin-dependent diabetes (IDDM) is an autoimmune disease with a strong genetic link to the HLA locus. It is less well understood, however, how the destruction of the insulin-producing beta cells is effected and why neighboring non-beta islet cells are spared. Also incompletely explained are the observations that, unlike other autoimmune diseases such as multiple sclerosis, IDDM does not preferentially affect females, the incidence of the disease is highest among young adults, and there are temporal correlations between the onset of the disease and emotional trauma. We have addressed some of these questions by using transgenic mice that constitutively express the MHC class I antigen Dd in the beta cells of the pancreas. Although both male and female Ins.Dd mice expressed equivalent amounts of the Dd protein only the males developed diabetes. The diabetes in the males could be reversed by castration, and the normoglycemic females became diabetic following either ovariectomy and the implantation of a slow-release pellet containing testosterone or the inclusion of dexamethasone in the drinking water. In contrast, transgenic mice that expressed the herpes simplex virus type 1 glycoprotein D in the pancreatic beta cells were normoglycemic and showed no obvious histopathological consequences. The observation that the beta-cell dysfunction by the increased expression of the MHC class I protein Dd cannot be induced by the herpes viral protein suggests that the cellular damage is related to a specific structure or function of the MHC proteins.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Diabetes Mellitus Tipo 1/inmunología , Antígenos de Histocompatibilidad Clase I/inmunología , Islotes Pancreáticos/inmunología , Simplexvirus/inmunología , Proteínas del Envoltorio Viral/inmunología , Animales , Dexametasona/farmacología , Diabetes Mellitus Tipo 1/patología , Femenino , Incidencia , Masculino , Ratones , Ratones Transgénicos/inmunología , Ovariectomía , Testosterona/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA